Deborah Armstrong, MD, Johns Hopkins Kimmel Cancer Center, discusses Early studies of enzastaurin and bevacizumab.

imedex has 1199 videos Subscribe Here

Description: Full interview...

* Early studies of enzastaurin and bevacizumab
* Single nucleotitde polymorphisms (SNPs)
* BRCA1 and association with clinical outcome in ovarian cancer patients
* OVA1 test
* Chemobrain in patients with ovarian cancer
Shared By : imedex
Posted on : 03/22/10
Added : 8 years ago
Category : Ovarian Cancer